Participation in Clinical Trials in the United States
On the evening of August 15, 2026, numerous challenges in connecting patients with clinical trials were reported across the U.S. A survey of over 2,000 adults revealed that while 71% of those with chronic illnesses expressed willingness to participate in trials, two-thirds had never had the topic introduced by their doctors. A 2020 study further found that only 9% of adults had ever received an invitation to join such trials.
The Importance and Challenges of Data Collection
Clinical trials are essential for developing new treatments and medical devices, ensuring safety and efficacy as approved by the U.S. Food and Drug Administration (FDA). However, recruitment often falls short, with up to 86% of trials failing to meet enrollment goals during the research phase. Experts also note that maintaining patient participation is even more difficult due to the multiple visits, procedures, and associated costs involved.
Policies and Initiatives Supporting Clinical Trial Participation
In June 2026, the U.S. Department of Health and Human Services (HHS) launched a project aimed at improving clinical research, which included assessing the removal of regulatory barriers that limit financial support for patients, such as travel and lodging expenses. The following month, nearly 200 healthcare organizations and advocacy groups jointly signed a letter urging the U.S.










